Pages
Search This Blog
Wednesday, February 26, 2025
Thank you OKP.
Friday, April 26, 2024
Apr 2024 Portfolio Update (Hong Kong Recovery, Cordlife Teaser)
Topics Discussed:
-Recovery of Hong Kong market and how it affects my option income portfolio
-Teaser post on Cordlife
S&P 500 (ytd): 9.3%
STI: 2.35%
Tracker Fund: 1.09%
My portfolio: 17.3%
Portfolio upsurge was contributed by the surge in OKP's share price, which stands at currently 40% of entire equities portfolio size. Clifford Modern Living announced a special dividend which brought the share price modestly. At this writing, it has already gone ex-dividend.
Other notable transactions made:
1) Complete divestment of very small holdings in Fraser's Hospitality Trust.
2) Purchase and increase of Cordlife; more on this later.
3) Huge increase in Clifford Modern Living, as detailed in the earlier post, "The Maths of CML"
***
Recovery in the HK Market and its effect on my option income portfolio
Not long after my remarks that option income strategies are far inferior to directional ones, the market decided that it is time for an upturn and the Hong Kong market staged a recovery of sorts.
Of the few stocks that I have interest on, and their last month performance, as follows:
1) Anta Sports (+9.7%)
Anta Sports was a very good opportunity missed. It was languishing around the low 70s and even 60s. Valuation at 70 was very good-- its current back-of-the-envelope valuation as follows:
Cash + short term investments: 36b RMB
Long term fixed deposits: 11.8b RMB
Debts (of all maturities): ~15b
Net Cash of 32.8b RMB, or 36.18
Earnings: 11.7b this year, 8.9b last. Give or take 10b, which is about 11b HKD
Market Cap: 253b HKD,
it was 200b HKD if its share price was 70 HKD
Market Cap less net cash: 217b HKD
that would be 164b HKD if its share price was 70 HKD
Given the rough earnings of 11b HKD, it is not very high price to pay about 15-16 times multiple for this kind of growth company. Anta is a owner-operator, so management motivation should not be a concern..
Unfortunately, opportunity loss. I was too concern with selling puts and selling calls, and I have a limited net asset value to maintain.
So I only have 400 shares of Anta Sports. I was quite bullish, even to to the point of selling in-the-money puts on Anta. They have since expire worthless.
2) Hong Kong Exchange (up 9.3%)
I do not think HKEX was cheap pre-recovery, so I wasn't too sore about this.
3) Link REIT (recovered 9% since 19-Apr).
Link has been quite volatile these days. Pre-recovery, I am looking at a loss of 25% on 1000 shares of Link, which means I could no longer sell calls without making a loss.
4) Tencent (up 15%)
Unfortunately, I am out of Tencent as they are called away. My opinion on the valuation of Tencent is not too dissimilar from HKEX's. It is not dirt cheap but it still feels like an opportunity missed.
5) Alibaba (up 9.5%)
My positions are still way underwater for this recovery to be meaningful.
On the whole, I count myself lucky that I covered the sold-calls on my Tracker Fund before the uptick. There is now a modest capital gain (my avg price is 17 HKD). I have sold calls at 18.5 till end of May, which net me a small premium of 0.275 per contract. That is a yield of (0.275/17) 1.6% for 1 month.
Assuming the HSI does have further legs upwards, I would use the funds on Cordlife, or to adopt a directional strategy on Hong Kong (using synthetics), or to sell put spreads, or even migrate over to America if there is a selldown.
***
Cordlife is a very interesting opportunity, which I would try to expound on in the next post. Its troubles began way before Nov-2023, the day where MOH began their investigation on the tanks. As I leafed through the annual reports for the last ten years, I think this is a pretty good opportunity. More later.
Wednesday, April 24, 2024
Another Year Passed (OKP AGM 2023)
It felt like just months ago that I attended OKP's 2022 Annual General Meeting (AGM), and yesterday, I attended 2023's.
I remember what happen in 2022's AGM (took place in Apr 2023) very well. At that point of time, the arbitration award was just been announced, and everyone was quizzing the management about the certainty of payment. I was persistent and questioned the financial controller about when it could be reflected, and she said that we will see it in Aug (i.e. the mid year results announcements).
Fast forward a few months, it was Aug 2023.
The 43m was in the balance sheet, but a not so special dividend was announced. Management was paid handsomely through bonuses. Investors were very disappointed. I remember the share price dropped quite badly.
OKP was (and still is) by far my biggest position. My portfolio and personal life was terrible in the last 2-3 years, and then when your biggest position goes up 20%... you thought that things are turning around ... only to lost it all in weeks.....Friday, March 31, 2023
March 2023 Portfolio Review
Year to date,
STI Index Fund returns +0.25% (was -0.52% in Feb)
Hong Kong Tracker Fund returns +1.8% (was 4.16%)
S&P 500 Index Fund returns +4.95% (was 6.05%)
My portfolio returns year-to-date is currently 6.11%. This excludes a substantial amount of Singapore Saving Bonds and T-Bills which I purchased on behalf of my mum. Bulk of these bonds will be redeemed or will mature in 2H 2023.
The returns look positive due to OKP. The market granted kindly a 23% revision upwards-- largely because OKP had been awarded a princely sum of 43m from its arbitration proceedings with CPG Consultants (market cap for OKP is still only 59m). CPG consultants were ordered to pay up 28 days from 3-March. The last I checked, OKP is still checking with its legal team if they have to make an announcement in SGX, when they are awarded the sum.
The returns were offset by colossal sell-downs by Central China Real Estate (CCRE) and Central China Management (CCMGT). The reason why I am extremely concerned by the wellbeing of these two holdings, due to the substantial amount of capital, valued at cost, invested. The amount represent #2 of my holdings (Alibaba is a distant #3). If the Chinese property sector does not recover, it would also impact Yangzijiang Finance (also a top 5 holding), which hold bonds mostly in China.
In just the past month alone, CCMGT lost 24%, and CCRE lost a blood-curdling 42.1%.
This is the second time in less than 2 years, which I have to endure drawdowns of this magnitude.
During the earnings release for CCMGT on 22-March-2023, the controlling shareholder, Mr Wong Po Sum ("Mr Wong") was extremely upbeat. He declared that the worst is over for CCMGT.
But the market vehemently disagreed.
Within a matter of days the stock fell from 56 cents to 48 cents. That is more than 15% in less than 5 days. While there was a rally of 9% today. I could find nothing to attribute such a market movement, and certainly there is nothing within CCRE's earning (that I just read) release to suggest that all is well.
Last but not least, Alibaba announced that they are splitting the business into 6 separate units, paving the way for spin-offs. The theoretical gap between market price and its sum-of-the-parts value could finally be bridged. I am not overly excited because I think there wasn't a huge value proposition-- too much assumptions regarding the cloud and fintech value (regarding the latter, I placed zero weight to private valuations by investment banks, regardless how prestigious they are).
Alibaba regained 16.41% in the last 5 trading days alone. In terms of cost, Alibaba is #3 in my portfolio, so it helps.
Earnings Release Review
There were many companies in my portfolio which release earnings this month.
I had just digested the release from CCRE and language does not appear to be upbeat, and neither were there any positives to take away. Dividend was withheld, which is sensible. There is a sum of 900m in bonds to be paid this year, and a default in any of them will trigger a cross-default to bonds maturing much latter. How strongly would the local banks of Henan support CCRE? My guess is as good as anyone.
The results from CCMGT isn't positive as well-- they appear to have lost their #2 position in management leadership in central China. The wisdom of the crowd surprises me, the price corrected to a 5% yield. So the market did not over-correct... Market efficiency should usually be respected.
A quick back of the envelope calculation suggest that the current price of CCMGT is at net current assets, with some blunt discounting of its receivables.
I just digested the results from Clifford Modern Living and the IT services segment was the only negative surprise. Dividend is maintained on a yearly basis. Cash in the books has increased, but the cashflow statement is not published in the unaudited release. I would examine it when the annual report is published.
Nanyang Holdings' result was out earlier this month. It has been a year and there is still no land use rights agreed upon for its Shanghai operations. It disappoints me greatly that the management persist in managing its investment in a overly-active manner, and to makes matter worse, the controlling shareholder has decided to rope in his daughter as an advisor (she had brilliant academic credentials but unfortunately is working in a unit trust/fund as well).
The Nanyang Plaza main tenant (of which about 15% of its revenue was attributed) has moved out. While the share prices for SCSB has risen since the rights issue, I think we may mistake symptoms for the cause. Only time could tell.
Despite the downcast report, Nanyang Holdings' price did not move at all due to illiquidity.
Transactions in March
I made a huge increase in OKP after earnings release. I think two things are probable here: 1st, CPG Consultants should be able to pay up; 2ndly, OKP's earnings should improve with its biggest order book in the last 5-6 years, since the incident.
There are areas which I am dissatisfied with this company (nothing is perfect in this world). I hope to be able to discuss this with management or like-minded shareholders next month during the AGM.
As of now, OKP is 33% of my entire holdings.
Comments
While I am grateful towards the increased share prices for some of my counters, the intellectual satisfaction was not there. I have held OKP for good 5-6 years since the incident, and Alibaba is a popular holding. I can't help feeling bitter by the manner which TTJ and Centurion owners treat its shareholders..
I find it deeply ironic that since young, I have a special place in my heart for the downtrodden, and this was a minor reason for buying such shares (the big reason is that they are undervalued, have problems, and have plenty of avenues to recover). It is regrettable that the attitude of these two companies management is no different from the market's as well.
If authors of investment books were to look for examples where management could be attributed for the poor share price performance of their companies, Centurion and TTJ would currently top the list.
Hope my fortune turnaround in the coming months.
Saturday, March 4, 2023
Feb 2023 Portfolio Update (Centurion, Yangzijiang Finance)
Despite sleeping very early these days, I was feeling perpetually tired throughout the day. That explains why this post is late.
I did a presentation some weeks back on value investing with Boon Tee:
STI Index Fund returns -0.52% (was 2.93% in Jan)
Hong Kong Tracker Fund returns 4.16% (was 7.84%)
S&P 500 Index Fund returns 6.05% (was 4.19%)
My portfolio returned a measly 4.25% (was 7.15%), largely due to another round of correction by Alibaba and Central China positions. This was very much inlin with expectation; the overhang (of property worries) should continue for years. Alibaba isn't doing so great, in terms of market price movements, but it does look like they have managed to control cost. However, Alicloud and International Operations continue to be loss making. There is still no clarity in how one should value Alicloud and the (potential?) Ant Group IPO.
Transactions:
Purchase 2000 shares of Nanyang Holdings for my portfolio.
Nanyang Holdings is just a very cheap stock which main operations are good old rental and investment. The main investment is of course their Shanghai Commercial and Savings Bank, which is mainly based in Taiwan. I would readily say that banks and financial institutions are far beyond my circle of competence. However, the value is still apparent in other aspects of its balance sheet. I am just uncomfortable with their investment process-- it is too active for its own good.
Discussion on OKP, Centurion and YZJ Finance, as they had released full year (FY) earnings during Feb 2023.
OKP:
While revenue is definitely higher, so are costs. The balance sheet looks far more fragile than a year ago, so now the investment thesis has become one of projection instead of protection. It was also revealed that 3m was spent in the arbitration with CPG Consultants. I believe, if OKP is successful, would bring significant one-off 'earnings' to the 53m market cap company.
********
Centurion:
As usual, the dividend is a joke, and the stock price corrected a fair amount (8% intraday at one point). The only bright spot is that the debt is getting reduced. Amusing enough, I think it is far better to be a debt holder in Centurion than a stock holder. It had been 2+ painful years.
Perhaps Centurion should do a major rights issue to bring down debt? Since the cost of equity (in dividends) is less than a Singapore Savings Bond? It wasn't that business was poor; things are actually picking up. So do the major rights issue, let's clear the debt in the books. In the mean time, management should show that they deserve to be management by:
a) Not increasing their remuneration, or best: be paid with stock options instead. Strike price should be significantly higher, lets say 25%, than prevailing market prices.
b) Voluntarily purchase securities in the open market.
On 22 Feb 2022, I wrote:
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Free Cash Flow (m) | 65.037 | 54.263 | 54.986 | 66.554 | 59.146 | 70.256 | 101.679 |
Dividend Declared (m) | 7.399 | 7.957 | 8.408 | 8.408 | 0 | 8.771 | 8.412 |
Interest payment | 21.383 | 21.545 | 23.929 | 28.759 | 23.319 | 22.734 | 28.341 |
Total Remuneration of Directors (Retrieved from Annual Reports, Sect. 9) | 0.38 | 0.422 | 2.113 | 2.422 | 2.68m | 3.277m | 2.971m (from earnings release) |
********
Asset | Stated Value | Discounted Value |
Cash and EQ | 620.6m | 620.6m |
Debt Investments | 2671m | 1348m |
Financial Assets (Investment in Chinese Equities) | 470.072 | 138m (unlisted equities are discounted by 75%) |
Investment in associated companies | 322m | 161m |
Total | 4083.6m | 2267.6m |
Wednesday, June 23, 2021
June 2021 Portfolio Review
Straits Times Index Fund: +11.07%
Hong Kong Tracker Fund: +8.61%
S&P 500 Index Fund: +15.34%
My Portfolio Returns: +41.57%
Transactions:
-Sold off a petty amount of Perfect Shape at 9.2$
PS still weighs at 28.4% of the entire portfolio. Results would be release on 30-June. Another announcement made, just this evening, is the reduction of board lot size from 4000 to 1000. This would no doubt increase liquidity (and speculation). The other action that would fuel further recklessness would be to split the shares 1-to-4.
I am still eagerly waiting for the results although I am leaning towards divestment. More on that later.
-Modest increase of OKP at 0.187-0.189
As I see no other opportunities in the market, coupled with the growing amount of unused cash for my parent's portfolio, I made a modest amount of purchase in this engineering company.
OKP is my second biggest position, standing at 22.9%
Days Sales Receivables Watch - Perfect Shape
While I am more than grateful for the capital gains (both unrealized and realized) brought about by this company, I am carefully watching the Day Sales Receivable (DSO) for this stock.
-
I have sold out of all my Cordlife shareholdings at 0.24 per share. This is a pretty good annualized return of 85% from about a year of hold...
-
Year to date: My portfolio: 56% S&P: 0.5% Tracker Fund: 13.34% STI: 8.68% Besides token amount of buying Powermatic Data, there isn...
Mid-August Portfolio Review
I know some of you are reading this because Kyith wrote about XB and I was mentioned. I just want to put this up right away: I don't hav...
